Antibodies to Dkk-1

Details for Australian Patent Application No. 2005267722 (hide)

Owner Amgen Inc.

Inventors Lu, Hsieng Sen; Shen, Wenyan; Richards, William Gleason; Li, Ji

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2005267722

PCT Pub. Number WO2006/015373

Priority 60/598,791 04.08.04 US

Filing date 4 August 2005

Wipo publication date 9 February 2006

Acceptance publication date 8 October 2009

International Classifications

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

Event Publications

15 February 2007 PCT application entered the National Phase

  PCT publication WO2006/015373 Priority application(s): WO2006/015373

8 October 2009 Application Accepted

  Published as AU-B-2005267722

4 February 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005267724-NOTCH mutations leading to increased receptor signaling

2005267720-Humanized anti-cmet antagonists